160 related articles for article (PubMed ID: 6879005)
1. Measles vaccines used in Japan.
Hirayama M
Rev Infect Dis; 1983; 5(3):495-503. PubMed ID: 6879005
[TBL] [Abstract][Full Text] [Related]
2. Development of measles vaccines in Japan.
Ueda S
Vaccine; 2009 May; 27(24):3230-1. PubMed ID: 19446197
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of two live measles vaccines in Iran.
Mirchamsy H; Shafyi A; Bassali Y; Bahrami S; Nazari F
J Hyg (Lond); 1970 Mar; 68(1):101-10. PubMed ID: 5266577
[TBL] [Abstract][Full Text] [Related]
4. A long-term follow-up study on the efficacy of further attenuated live measles vaccine, Biken CAM vaccine.
Isomura S; Morishima T; Nishikawa K; Hanada N; Rahman M; Terashima M; Kido S; Ueda S; Takahashi M
Biken J; 1986 Mar; 29(1):19-26. PubMed ID: 3778422
[TBL] [Abstract][Full Text] [Related]
5. Clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine. Fourth report to the medical research council by the measles sub-committee of the committee on development of vaccines and immunisation procedures.
Lancet; 1977 Sep; 2(8038):571-5. PubMed ID: 71396
[TBL] [Abstract][Full Text] [Related]
6. A controlled trial for evaluating two live attenuated mumps-measles vaccines (Urabe Am 9-Schwarz and Jeryl Lynn-Moraten) in young children.
Popow-Kraupp T; Kundi M; Ambrosch F; Vanura H; Kunz C
J Med Virol; 1986 Jan; 18(1):69-79. PubMed ID: 3511182
[TBL] [Abstract][Full Text] [Related]
7. Divergent mortality for male and female recipients of low-titer and high-titer measles vaccines in rural Senegal.
Aaby P; Samb B; Simondon F; Knudsen K; Seck AM; Bennett J; Whittle H
Am J Epidemiol; 1993 Nov; 138(9):746-55. PubMed ID: 8237989
[TBL] [Abstract][Full Text] [Related]
8. Immunization of children with attenuated measles-rubella bivalent vaccine.
Ramos-Alvarez M; Miller BH; Jackson JE; Schwarz AJ; Bessudo L
Am J Dis Child; 1975 Apr; 129(4):474-7. PubMed ID: 1093389
[TBL] [Abstract][Full Text] [Related]
9. Comparison of AIK-C measles vaccine in infants at 6 months with Schwarz vaccine at 9 months: a randomized controlled trial in Ghana.
Nkrumah FK; Osei-Kwasi M; Dunyo SK; Koram KA; Afari EA
Bull World Health Organ; 1998; 76(4):353-9. PubMed ID: 9803586
[TBL] [Abstract][Full Text] [Related]
10. Measles and measles vaccine in Japan.
Isomura S
Nagoya J Med Sci; 1993 Mar; 55(1-4):23-32. PubMed ID: 8247103
[TBL] [Abstract][Full Text] [Related]
11. Incidence of subacute sclerosing panencephalitis following measles and measles vaccination in Japan.
Okuno Y; Nakao T; Ishida N; Konno T; Mizutani H; Fukuyama Y; Sato T; Isomura S; Ueda S; Kitamura I
Int J Epidemiol; 1989 Sep; 18(3):684-9. PubMed ID: 2807674
[TBL] [Abstract][Full Text] [Related]
12. Studies on measles in Thailand. VI. A clinical trial of "CAM 70" measles virus vaccine in home-dwelling children.
Sangkawibha N; Ueda S; Tuchinda P; Sakuntanaga P; Sunthonsaratul A
Biken J; 1973 Dec; 16(4):167-71. PubMed ID: 4799209
[No Abstract] [Full Text] [Related]
13. Comparative study of the reaction-causing properties and the immunological and epidemiological effectiveness of Leningrad-16 and Schwarz live measles vaccines.
Bolotovskij VM; Zetilova LP
Bull World Health Organ; 1968; 39(2):293-8. PubMed ID: 4881072
[TBL] [Abstract][Full Text] [Related]
14. Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines.
Markowitz LE; Sepulveda J; Diaz-Ortega JL; Valdespino JL; Albrecht P; Zell ER; Stewart J; Zarate ML; Bernier RH
N Engl J Med; 1990 Mar; 322(9):580-7. PubMed ID: 2304505
[TBL] [Abstract][Full Text] [Related]
15. Immunization against measles by aerosol.
Sabin AB
Rev Infect Dis; 1983; 5(3):514-23. PubMed ID: 6348918
[TBL] [Abstract][Full Text] [Related]
16. [Experiment of vaccination against measles using attenuated virus (Schwarz strain) (author's transl)].
Trivello R; Renzulli G; Romano M; Milone G; Moschen ME
Ann Sclavo; 1978; 20(2):113-20. PubMed ID: 742926
[No Abstract] [Full Text] [Related]
17. Comparative analysis of host responses related to immunosuppression between measles patients and vaccine recipients with live attenuated measles vaccines.
Okada H; Sato TA; Katayama A; Higuchi K; Shichijo K; Tsuchiya T; Takayama N; Takeuchi Y; Abe T; Okabe N; Tashiro M
Arch Virol; 2001; 146(5):859-74. PubMed ID: 11448026
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of transcutaneous vaccination using a patch with the live-attenuated measles vaccine in humans.
Etchart N; Hennino A; Friede M; Dahel K; Dupouy M; Goujon-Henry C; Nicolas JF; Kaiserlian D
Vaccine; 2007 Sep; 25(39-40):6891-9. PubMed ID: 17764789
[TBL] [Abstract][Full Text] [Related]
19. Experimental vaccines against measles in a world of changing epidemiology.
Pütz MM; Bouche FB; de Swart RL; Muller CP
Int J Parasitol; 2003 May; 33(5-6):525-45. PubMed ID: 12782053
[TBL] [Abstract][Full Text] [Related]
20. Antibody response and clinical reactions in children given measles vaccine with immunoglobulin.
Elliman D
Br Med J (Clin Res Ed); 1986 Jun; 292(6535):1597-8. PubMed ID: 3087532
[No Abstract] [Full Text] [Related]
[Next] [New Search]
